Physician profile
Marijke Julia Devos
NPI 1356874952
$15,239.68
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14K · 2023: $1,628 · 2024: $69.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2022 | |
| Medinc of Texas | $2,599.46 | 2022 | |
| Stryker Corporation | $1,170.12 | 2022-2024 | Gamma, Variax, Asnis |
| Axogen | $466.40 | 2023 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Acumed LLC | $426.01 | 2023 | Acumed, Inframe Implant |
| Trimed, INC. | $171.68 | 2023 | |
| Endo Pharmaceuticals INC. | $159.74 | 2023 | Xiaflex |
| Integra Lifesciences Corporation | $127.86 | 2022 | |
| Smith+Nephew, INC. | $118.41 | 2023 | Evos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marijke Devos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.